Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biotechnology and Bioengineering|May 28, 2010
Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesisKirsten Schroer, Matthias Kittelmann, Stephan Lütz
Applied Microbiology and Biotechnology|May 23, 2007
Biocatalytic ketone reduction--a powerful tool for the production of chiral alcohols--part I: processes with isolated enzymesKatja Goldberg, Kirsten Schroer, Stephan Lütz, et al.
Biotechnology and Bioengineering|June 3, 2009
Metabolomics for biotransformations: Intracellular redox cofactor analysis and enzyme kinetics offer insight into whole cell processesKirsten Schroer, Bruno Zelic, Marco Oldiges, et al.
Applied Microbiology and Biotechnology|May 9, 2007
Biocatalytic ketone reduction--a powerful tool for the production of chiral alcohols-part II: whole-cell reductionsKatja Goldberg, Kirsten Schroer, Stephan Lütz, et al.
Metabolic Engineering|September 1, 2009
Engineering the Pichia pastoris methanol oxidation pathway for improved NADH regeneration during whole-cell biotransformationKirsten Schroer, Klaus Peter Luef, Franz Stefan Hartner, et al.
Applied Microbiology and Biotechnology|August 1, 2007
Metabolomics: current state and evolving methodologies and toolsMarco Oldiges, Stephan Lütz, Simon Pflug, et al.
Journal of Industrial Microbiology & Biotechnology|March 26, 2014
Definition of culture conditions for Arxula adeninivorans, a rational basis for studying heterologous gene expression in this dimorphic yeastChristoph Stöckmann, Thomas G Palmen, Kirsten Schroer, et al.
Angewandte Chemie (International Ed. in English)|October 8, 2019
Evolved Aliphatic Halogenases Enable Regiocomplementary C-H Functionalization of a Pharmaceutically Relevant CompoundTakahiro Hayashi, Mathieu Ligibel, Emine Sager, et al.
Chimia|December 4, 2023
Evolution of Biocatalysis at Novartis over the last 40 YearsElina Siirola, Fabian Eggimann, Charles Moore, et al.
Pageof 2